home / stock / grx / grx news


GRX News and Press, The Gabelli Healthcare & Wellness Trust of Beneficial Interest From 07/08/20

Stock Information

Company Name: The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Stock Symbol: GRX
Market: NYSE
Website: www.gabelli.com

Menu

GRX GRX Quote GRX Short GRX News GRX Articles GRX Message Board
Get GRX Alerts

News, Short Squeeze, Breakout and More Instantly...

GRX - Weekly Closed-End Fund Roundup: June 28, 2020

Author's note: this article was released to members of CEF/ETF Income Laboratory on June 28, 2020. Please check latest data before investing. The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movements in closed-end fund [CEF] sectors ...

GRX - Malaria drug fails to show benefit in COVID-19 study

An observational study involving COVID-19 patients treated at New York-Presbyterian Hospital-Columbia University Irving Medical Center did not show a treatment benefit from the use of malaria drug hydroxychloroquine. The results were just published in the New England Journal of Medicine ....

GRX - Gabelli Funds, LLC Announces Change to Virtual Meetings for Closed-End Funds Annual Meetings on May 11, 2020

The following notice relates to the Annual Meetings of: Bancroft Fund Ltd. Ellsworth Growth and Income Fund Ltd. GAMCO Global Gold, Natural Resources & Income Trust GAMCO Natural Resources, Gold & Income Trust The Gabelli Convertible & Income Securities Fund ...

GRX - Weekly Closed-End Fund Roundup: ASG/USA Lower Distributions (April 17, 2020)

Author's note: This article was initially released to members on April 20, 2020. The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movements in closed-end fund [CEF] sectors in the last week, as well as to highlight recently concluded ...

GRX - FDA cautions on use of malaria drugs for COVID-19 outside of hospitals

In a statement , the FDA is cautioning against the use of malaria meds chloroquine and hydroxychloroquine outside of the hospital setting for the treatment of COVID-19 due to the risk of adverse heart rhythm side effects. More news on: Tekla World Healthcare Fund, BlackRock Health Science...

GRX - Coronavirus cases 10x - 20x higher than reported - former FDA Commish

Former FDA Commissioner Scott Gottlieb, M.D. is joining the growing chorus of experts who believe that the actual number of COVID-19 infections in the U.S. is substantially higher than reported, as much as 20 times higher he says. More news on: Tekla World Healthcare Fund, BlackRock Health...

GRX - U.S. COVID-19 testing capacity still constrained - AACC

In a statement , the American Association of Clinical Chemistry (AACC), a clinical laboratory industry group, says the scarcity of essential gear, including sample collection (nasal swabs) and test components and personal protective equipment, will continue to hamper the nation's labs in ex...

GRX - Weekly Closed-End Fund Roundup: Rebound Week (March 27, 2020)

Author's note : This article was released to CEF/ETF Income Laboratory members on March 30, 2020, and includes a rare reposting of our weekly commentary and actionable ideas. The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movements...

GRX - Malaria drugs in high demand amid COVID-19

States across the U.S. are instituting measures to prevent hoarding of malaria drugs hydroxychloroquine and chloroquine in an effort to maintain supply amid acute demand from pharmacies and COVID-19 patients. More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The...

GRX - New York "not ready" for high point of COVID-19 pandemic - Gov. Cuomo

New York Governor Andrew Cuomo is warning that the state is still not ready to handle the peak number COVID-19 cases, expected in the next seven days or so. More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The Gabelli Healthcare & Wellness Rx Trust, Healthc...

Previous 10 Next 10